ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.305,57
-0,34%
S&P 500
5.304,72
0,70%
US Dollar vs BRL
5,13862
-0,55%
Bitcoin
69.100,00
0,83%
Brent Oil
81,965
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Canadá
  5. TSX
  6. Bausch Health Companies Inc (BHC)

  7. Bausch Health Companies Inc (BHC) Notícias

BHC

Bausch Health Companies (BHC)

Bausch Health Companies Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:TSX:BHC
DataHoraFonteTítuloCódigoCompanhia
11/04/202412:17PR Newswire (Canada)L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - BHCTSX:BHCBausch Health Companies Inc
11/04/202412:17PR Newswire (Canada)Canadian Investment Regulatory Organization Trade Resumption - BHCTSX:BHCBausch Health Companies Inc
11/04/202412:08PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - BHCTSX:BHCBausch Health Companies Inc
11/04/202412:03PR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - BHCTSX:BHCBausch Health Companies Inc
31/05/202309:00PR Newswire (US)OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum DiseaseTSX:BHCBausch Health Companies Inc
17/05/202314:34PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - BHCTSX:BHCBausch Health Companies Inc
17/05/202314:33PR Newswire (Canada)IIROC Trade Resumption - BHCTSX:BHCBausch Health Companies Inc
17/05/202314:18PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - BHCTSX:BHCBausch Health Companies Inc
17/05/202314:17PR Newswire (Canada)IIROC Trading Halt - BHCTSX:BHCBausch Health Companies Inc
17/05/202313:43PR Newswire (Canada)ttIIROC Trading Halt - BHCTSX:BHCBausch Health Companies Inc
03/05/202307:58PR Newswire (Canada)RYALTRIS®, a new combination prescription nasal spray for moderate to severe seasonal allergic rhinitis (SAR), now available across CanadaTSX:BHCBausch Health Companies Inc
03/05/202307:58PR Newswire (Canada)RYALTRIS(MD), une nouvelle association sous ordonnance en pulvérisateur nasal pour la rhinite allergique saisonnière (RAS) d'intensité modérée à grave, est maintenant disponible partout au CanadaTSX:BHCBausch Health Companies Inc
22/12/202208:59PR Newswire (Canada)First tazarotene lotion treatment for acne vulgaris, ARAZLO™ (tazarotene lotion, 0.045%), now available to patients through Quebec, Ontario, Alberta, Saskatchewan and federal NIHB public drug plansTSX:BHCBausch Health Companies Inc
22/12/202208:59PR Newswire (Canada)ARAZLOMC (lotion de tazarotène, 0,045 %), la première lotion à base de tazarotène indiquée pour le traitement de l'acné vulgaire, est maintenant offerte aux patients du Québec, de l'Ontario, de l'Alberta et de la Saskatchewan dans le cadre des régiTSX:BHCBausch Health Companies Inc
12/10/202209:00PR Newswire (Canada)SALIX PHARMACEUTICALS RELEASES LIVER HEALTH ANNUAL TRENDS REPORT UNDERSCORING CHALLENGES IN CARING FOR GROWING CHRONIC LIVER DISEASE AND CIRRHOTIC PATIENT POPULATIONTSX:BHCBausch Health Companies Inc
05/10/202209:00PR Newswire (US)Seasonal Affective Disorder (SAD) Is Now a Recognized Diagnosis in the CMS Tabular Index, Accessible to Prescribers Oct. 1, 2022TSX:BHCBausch Health Companies Inc
03/10/202209:00PR Newswire (US)SALIX PHARMACEUTICALS APPLAUDS IMPLEMENTATION OF K76.82 - A NEW ICD-10 CODE FOR HEPATIC ENCEPHALOPATHYTSX:BHCBausch Health Companies Inc
28/09/202209:09PR Newswire (US)Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent SolicitationsTSX:BHCBausch Health Companies Inc
23/09/202207:59PR Newswire (Canada)Bausch Health and Glenmark Announce the approval of RYALTRIS® in CanadaTSX:BHCBausch Health Companies Inc
23/09/202207:59PR Newswire (Canada)Bausch Health et Glenmark annoncent l'approbation du RYALTRIS MD au CanadaTSX:BHCBausch Health Companies Inc
14/09/202210:00PR Newswire (US)Bausch Health Announces Early Exchange Offer Results for Exchange Offers and Consent SolicitationsTSX:BHCBausch Health Companies Inc
09/09/202208:00PR Newswire (Canada)Bausch Health Responds to Norwich Pharmaceuticals Tentative FDA Approval for a 200 mg RifaximinTSX:BHCBausch Health Companies Inc
08/09/202217:45PR Newswire (US)Bausch Health Clarifies Release Provisions Related to its Exchange Offers and Consent SolicitationsTSX:BHCBausch Health Companies Inc
02/09/202219:27PR Newswire (Canada)S&P Dow Jones Indices annonce des modifications à l'indice composé S&P/TSX et à l'indice S&P/TSX 60TSX:BHCBausch Health Companies Inc
02/09/202218:15PR Newswire (Canada)S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index and S&P/TSX 60 IndexTSX:BHCBausch Health Companies Inc
31/08/202200:28PR Newswire (US)Bausch Health Announces Exchange Offers and Consent Solicitations for Certain Existing Senior Notes with Support from Approximately 23% of Outstanding Existing Senior NotesTSX:BHCBausch Health Companies Inc
22/08/202208:00PR Newswire (US)Bausch Health Continuing Process Toward Separating Bausch + LombTSX:BHCBausch Health Companies Inc
10/08/202219:00PR Newswire (Canada)Bausch Health to Appeal XIFAXAN® Patent Decision to U.S. Court of Appeals for the Federal CircuitTSX:BHCBausch Health Companies Inc
10/08/202208:00PR Newswire (US)Salix Supports CMS Announcement of First ICD-10 Code for Hepatic Encephalopathy (HE)TSX:BHCBausch Health Companies Inc
09/08/202208:00PR Newswire (Canada)BAUSCH HEALTH ANNOUNCES SECOND-QUARTER 2022 RESULTSTSX:BHCBausch Health Companies Inc
 Apresentando as notícias mais relevantes sobre:TSX:BHC

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
PSVM11
PORTO SUDESTE
BOV
HOOT4
HOTEIS OTHON PN
BOV
GOLL4
GOL PN
BOV
PETZ3
Pet Center Comercio E Pa... ON
BOV
AMER3
Americanas ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados